XLO XILIO THERAPEUTICS INC Investor Conferences 8-K Filing 2023 - Presentation and Clinical Trial Update Xilio Therapeutics, Inc. presents its corporate slide presentation to the investment community and announces preliminary monotherapy data from its Phase 1 clinical trial.Get access to all SEC 8-K filings of the XILIO THERAPEUTICS INC